| 3.12 Data as of 3:59pm ET |  -0.04 / -1.27%Today’s Change | 2.91 Today|||52-Week Range 8.18 | -48.51% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $56.0M |
Cyclacel Pharmaceuticals, Inc. 200 Connell Drive Berkeley Heights New Jersey 07922-2811 |
| Other institutional | 16.92% |
| Mutual fund holders | 1.89% |
| Individual stakeholders | 1.86% |
| Spiro Rombotis, MBA | President, Chief Executive Officer & Director |
| Paul McBarron | COO, CFO, Secretary, Director & Executive VP |
| David Glover, PhD | Chief Scientist |
| Susan Davis, PhD | Director-Business Development |
| Corey Sohmer | Head-Corporate Communications & Investor Relations |
.
